Bringing new players into the field: onco-pharmacovigilance in the era of cardio-oncology

Intern Emerg Med. 2012 Apr;7(2):99-101. doi: 10.1007/s11739-012-0756-2. Epub 2012 Jan 22.
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Cardiology / standards
  • Cardiology / trends
  • Cardiovascular Diseases / chemically induced*
  • Humans
  • Interdisciplinary Communication*
  • Medical Oncology / standards
  • Medical Oncology / trends
  • Pharmacovigilance*
  • Safety Management

Substances

  • Antineoplastic Agents